Nalbuphine and Convulsion - a phase IV clinical study of FDA data

Summary:

Convulsion is reported as a side effect among people who take Nalbuphine (nalbuphine hydrochloride), especially for people who are female, 10-19 old, have been taking the drug for < 1 month also take Ondansetron, and have Acute myeloid leukaemia.

The phase IV clinical study analyzes which people have Convulsion when taking Nalbuphine. It is created by eHealthMe based on reports of 1,089 people who have side effects when taking Nalbuphine from the FDA, and is updated regularly.

What is Nalbuphine?

Nalbuphine has active ingredients of nalbuphine hydrochloride. eHealthMe is studying from 1,091 Nalbuphine users. Check the latest studies of Nalbuphine.

What is Convulsion?

Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body) is found to be associated with 1,850 drugs and 2,856 conditions by eHealthMe. Check the latest studies of Convulsion.

On Aug, 06, 2026

1,089 people reported to have side effects when taking Nalbuphine.
Among them, 24 people (2.2%) have Convulsion.

Among these 24 people:

How long have people been on Nalbuphine when they have Convulsion? *

What is the gender of people who have Convulsion when taking Nalbuphine? *

female: 61.9 %
male: 38.1 %

What is the age of people who have Convulsion when taking Nalbuphine? *

What are other drugs people take besides Nalbuphine? *

What are other side effects people have besides Convulsion? *

Thrombocytopenia (decrease of platelets in blood): 9 people, 37.50%
Nervous System Disorder (a general class of medical conditions affecting the nervous system): 7 people, 29.17%
Mucosal Inflammation (infection of mucous membrane): 6 people, 25.00%
Intraventricular Haemorrhage (intraventricular bleeding): 6 people, 25.00%
Sepsis (a severe blood infection that can lead to organ failure and death): 6 people, 25.00%
Cerebral Palsy: 6 people, 25.00%
Subarachnoid Haemorrhage (blood leaks into the space between two membranes that surround the brain): 6 people, 25.00%
White Blood Cell Count Abnormal: 5 people, 20.83%
Visual Impairment: 5 people, 20.83%
Haemorrhage (bleeding): 5 people, 20.83%

What are the existing conditions these people have? *

Stress And Anxiety: 4 people, 16.67%
Pain: 4 people, 16.67%
Nausea (feeling of having an urge to vomit): 4 people, 16.67%
Fever: 4 people, 16.67%
Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 4 people, 16.67%
Analgesic Effect: 3 people, 12.50%
Infection: 2 people, 8.33%
Hodgkin's Lymphoma (cancer originating from white blood cells): 2 people, 8.33%
Bone Sarcoma (bone cancer): 2 people, 8.33%
Sedation: 1 person, 4.17%

* Approximation only. Some reports may have incomplete information.

Do you take Nalbuphine and have Convulsion?

- Check whether Convulsion is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Nalbuphine:

Nalbuphine (1,091 reports)

Convulsion treatments and more:

Convulsion (99,535 reports)

Browse all side effects of Nalbuphine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Convulsion:

Convulsion (1,850 drugs)

Browse all the conditions that are associated with Convulsion:

Convulsion (2,856 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on nalbuphine hydrochloride (the active ingredients of Nalbuphine) and Nalbuphine (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.